FDA Adverse Event Injury Summary report: N

ARTICULEZE M HEAD 36MM +15.5

MDR report key: 3896643 · Received June 26, 2014

Report

Report Number
1818910-2014-22082
Event Type
Injury
Date Received
June 26, 2014
Date of Event
May 27, 2014
Report Date
May 27, 2014
Manufacturer
DEPUY INTERNATIONAL LTD.-8010379
Product Code
JDI
PMA / PMN Number
PK980513
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

DISLOCATED HIP. BROKEN CONSTRAINING RING ON A CONSTRAINED LINER. DOI: (B)(6) 2013, DOR: (B)(6) 2014 (LEFT HIP). THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. A COMPLAINT DATABASE SEARCH FINDS NO ADDITIONAL REPORTS AGAINST THE PROVIDED PRODUCT AND LOT COMBINATIONS. A REVIEW OF THE DEVICE HISTORY RECORDS FOR THE FK4LY1 LOT CODE DID NOT REVEAL ANY RELATED MANUFACTURING DEVIATIONS OR ANOMALIES. REQUESTS FOR ADDITIONAL INVESTIGATIONAL INPUTS WERE MADE IN ACCORDANCE WITH WI-7915 APPENDIX A. NO ADDITIONAL INFORMATION WAS OBTAINED. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO IDENTIFY ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Description of Event or Problem · 1

DISLOCATED HIP. BROKEN CONSTRAINING RING ON A CONSTRAINED LINER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
373495 ARTICULEZE M HEAD 36MM +15.5 HIP FEMORAL HEAD JDI DEPUY INTERNATIONAL LTD.-8010379 3558011

Patients

Seq Age Sex Outcome Treatment
1 57 YR Required Intervention